UPDATE: Keryx Biopharmaceuticals Posts Q4 Loss

By: via Benzinga
Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) reported a loss in the fourth quarter. The New York-based company reported a quarterly ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.